Using of MRI-guided focused ultrasound treatment for Parkinson’s disease tremor. Clinical case and literature review
https://doi.org/10.30629/2658-7947-2022-27-6-56-62
Abstract
MRI-guided high-intensity focused ultrasound (MRgFUS) is a new emerging and promising procedure applied in a wide range of clinical fi elds in modern medicine. This innovative treatment method follows is an important step towards the ideal surgery of the future: non-invasive, targeted, safe, controlled, eff ective and ambulatory. Randomized studies show high effi cacy in the treatment of tremor for Parkinson disease and essential tremor. Safety is also having similar profi le with other surgical procedures and has a mostly transient character of complications. Such advantages as a non-invasive treatment, controlled eff ect and the safety profi le of the procedure made it popular in the treatment of movement disorders. This article demonstrates a clinical case of the fi rst using of MRgFUS for the treatment of Parkinson’s disease tremor at the Federal Center for Brain Research and Neurotechnologies of the Federal Medical and Biological Agency of Russia in Moscow. The 54-year-old patient with Parkinson disease, 2 Hoehn–Yahr, admitted to our hospital. Severe tremor of right upper extremity impaired his life. Neurosurgical procedure was considered due to medication failed. Patient underwent focused ultrasound thalamotomy with totally tremor relief. No additional neurological impairment was noted, only bradykinesia and rigidity were improved. Patient discharged on 3rd day after the procedure.
Conclusions. MRgFUS is an innovative surgical procedure. Advantages of these methods such as non-invasive manner, controlled, safety allowed to be priority procedure for patients with unilateral tremor.
About the Authors
M. Y. DzhafarovaRussian Federation
Moscow
V. M. Dzhafarov
Russian Federation
Moscow
I. V. Senko
Russian Federation
Moscow
V. V. Belousov
Russian Federation
Moscow
References
1. Meng Y., Hynynen K., Lipsman N. Applications of focused ultrasound in the brain: from thermoablation to drug delivery. Nat Rev Neurol. 2020;17(1):7–22. https://doi.org/10.1038/s41582-020-00418-z
2. Postuma R.B., Berg D., Stern M., Poewe W., Olanow W., Oertel W. et al. MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord. 2015;30(12):1591–601. https://doi.org/10.1002/mds.26424
3. Tyurnikov V.M., Gushcha A.O. High-intensity focused ultrasound in functional neurosurgery. Annals of Clinical and Experimental Neurology. 2016;10(4):5–10. (In Russ). https://doi.org/10.17816/psaic21
4. Elias W.J., Lipsman N., Ondo W.G., Ghanouni P., Kim Y.G., Lee W. et al. A randomized trial of focused ultrasound thalamotomy for essential tremor. N Engl J Med. 2016;375:730–9. https://doi.org/10.1056/NEJMc1612210
5. Bond A.E., Shah B.B., Huss D.S., Dallapiazza R.F., Warren A., Harrison M.B. et al. Safety and effi cacy of focused ultrasound thalamotomy for patients with medication-refractory, tremordominant parkinson disease: a randomized clinical trial. JAMA Neurol. 2017;74:1412–8. https://doi.org/10.1001/jamaneurol.2017.3098
6. Jeanmonod D., Werner B., Morel A., Michels L., Zadicario E., Schiff G., Martin E. Transcranial magnetic resonance imagingguided focused ultrasound: noninvasive central lateral thalamotomy for chronic neuropathic pain. Neurosurg Focus. 2012;32:E1. https://doi.org/10.3171/2011.10.FOCUS11248
7. Galimova R.M., Illarioshkin S.N., Buzaev I.V., Kachemaeva O.V. Movement disorders therapy by magnetic resonance-guided focused ultrasound. Recommendations for neurologists for patient selection. Bulletin of national society for movements disorders study (Byulleten’ Nacional’nogo obshchestva po izucheniyu bolezni Parkinsona i rasstrojstv dvizhenij). 2020;1:9–15. (In Russ). https://doi.org/10.24411/2226-079X-2020-12168
8. Martínez-Fernández R., Máñez-Miró J., Rodríguez-Rojas R., Álamo M., Shah B., Hernández-Fernández F. et al. Randomized Trial of Focused Ultrasound Subthalamotomy for Parkinson’s Disease. N Engl J Med. 2020;383(26):2501–2513. https://doi.org/10.1056/nejmoa2016311
9. Mohammed N., Patra D., Nanda A. A meta-analysis of outcomes and complications of magnetic resonance–guided focused ultrasound in the treatment of essential tremor. Neurosurg Focus. 2018;44(2). https://doi.org/10.3171/2017.11.FOCUS17628
10. Park Y., Jung N., Na Y., Chang J. Four-year follow-up results of magnetic resonance-guided focused ultrasound thalamotomy for essential tremor. Mov Disord. 2019;34(5):727–734. https://doi.org/10.1002/mds.27637
11. Sinai A., Nassar M., Sprecher E., Constantinescu M., Zaaroor M., Schlesinger I. Focused Ultrasound Thalamotomy in Tremor Dominant Parkinson’s Disease: Long-Term Results. J Parkinsons Dis. 2021:1–8. https://doi.org/10.3233/jpd-212810
12. Altinel Y., Alkhalfan F., Qiao N., Velimirovic M. Outcomes in Lesion Surgery versus Deep Brain Stimulation in Patients with Tremor: A Systematic Review and Meta-Analysis. World Neurosurg. 2019;123:443–452. https://doi.org/10.1016/j.wneu.2018.11.175
13. Harary M., Segar D., Hayes M., Cosgrove G. Unilateral Thalamic Deep Brain Stimulation Versus Focused Ultrasound Thalamotomy for Essential Tremor. World Neurosurg. 2019;126:144–152. https://doi.org/doi:10.1016/j.wneu.2019.01.281
Review
For citations:
Dzhafarova M.Y., Dzhafarov V.M., Senko I.V., Belousov V.V. Using of MRI-guided focused ultrasound treatment for Parkinson’s disease tremor. Clinical case and literature review. Russian neurological journal. 2022;27(6):56-62. (In Russ.) https://doi.org/10.30629/2658-7947-2022-27-6-56-62